3
Aug 2026
Gestational diabetes cases surge across England, raising health concerns
One in eight mothers in England is now diagnosed with gestational diabetes, with diagnoses rising by 60 per cent in just five years, according to a major study.
STAY INFORMED!
3
Aug 2026
Current NICE criteria miss most younger women at breast cancer risk
The National Institute for Health and Care Excellence (NICE) criteria used to decide who should be referred by GPs for further breast cancer risk assessment and specialist care misses up to 95% of women under 50 who will go on to develop the disease in the next 10 years, new research by researchers at the University of Cambridge and The Institute of Cancer Research, London, has found.
3
Aug 2026
Broader autism definition may lead to confusion and possible misdiagnosis
The definition of autism may have become so wide that it risks confusion and even misdiagnosis, according to a new editorial by UCL Professor Dame Uta Frith, whose pioneering research in the 1960s and 70s lay the foundations for how we understand autism.
3
Aug 2026
AI could play a role in the development of low-cost technologies for monitoring foot health
Researchers have demonstrated AI tools could play an important part in the development of simpler, lower-cost technologies for monitoring foot health, particularly in settings where access to specialised equipment may be limited.
Why Us?
Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.